{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T04:31:26Z","timestamp":1765859486149,"version":"3.48.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012650","name":"Technische Universit\u00e4t Wien Bibliothek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012650","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.phro.2025.100855","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:29:47Z","timestamp":1761870587000},"page":"100855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Risk of genitourinary late effects after radiotherapy for prostate cancer associated with early changes in bladder shape"],"prefix":"10.1016","volume":"36","author":[{"given":"Oscar","family":"Casares-Magaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata G.","family":"Raidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Furmanov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niclas","family":"Pettersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitali","family":"Moiseenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Einck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin","family":"Hopper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rick","family":"Knopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludvig P.","family":"Muren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phro.2025.100855_b0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.radonc.2017.12.022","article-title":"Standard whole prostate gland radiotherapy with and without lesion boost in prostate cancer: Toxicity in the FLAME randomized controlled trial","volume":"127","author":"Monninkhof","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2025.100855_b0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijrobp.2020.01.052","article-title":"Phase I trial of MRI-guided prostate cancer lattice extreme ablative dose (LEAD) boost radiation therapy","volume":"107","author":"Pollack","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2025.100855_b0015","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S1470-2045(19)30569-8","article-title":"Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial","volume":"20","author":"Brand","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.phro.2025.100855_b0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.radonc.2019.12.006","article-title":"Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): a randomised trial","volume":"145","author":"Murthy","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2025.100855_b0025","doi-asserted-by":"crossref","DOI":"10.1007\/s00066-023-02104-7","article-title":"Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation","volume":"200","author":"Moll","year":"2024","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.phro.2025.100855_b0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.radonc.2019.02.014","article-title":"Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology\/RTOG 0415","volume":"135","author":"Thor","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2025.100855_b0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2019.02.018","article-title":"Late toxicity after single dose HDR prostate brachytherapy and EBRT for localized prostate cancer: Clinical and dosimetric predictors in a prospective cohort study","volume":"135","author":"B\u00fcchser","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2025.100855_b0040","article-title":"Dose-volume relationships of planned versus estimated delivered radiation doses to pelvic organs at risk and side effects in patients treated with salvage radiotherapy for recurrent prostate cancer","author":"J\u00f3hannesson","year":"2023","journal-title":"Tech Innov Pat Supp Radiat Oncol"},{"key":"10.1016\/j.phro.2025.100855_b0045","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.ejmp.2016.08.013","article-title":"Bladder spatial-dose descriptors correlate with acute urinary toxicity after radiation therapy for prostate cancer","volume":"32","author":"Improta","year":"2016","journal-title":"Phys Med"},{"key":"10.1016\/j.phro.2025.100855_b0050","article-title":"Predictors for late genitourinary toxicity in men receiving radiotherapy for high-risk prostate cancer using planned and accumulated dose","volume":"25","author":"Li Kuan Ong","year":"2023","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.phro.2025.100855_b0055","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1080\/0284186X.2017.1312014","article-title":"Associations between volume changes and spatial dose metrics for the urinary bladder during local versus pelvic irradiation for prostate cancer","volume":"56","author":"Casares-Magaz","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.phro.2025.100855_b0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.phro.2018.09.005","article-title":"A case-control study using motion-inclusive spatial dose-volume metrics to account for genito-urinary toxicity following high-precision radiotherapy for prostate cancer","volume":"7","author":"Casares-Magaz","year":"2018","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.phro.2025.100855_b0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.radonc.2016.02.025","article-title":"First application of a pixel-wise analysis on bladder dose-surface maps in prostate cancer radiotherapy","volume":"119","author":"Palorini","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2025.100855_b0070","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijrobp.2019.01.088","article-title":"Voxel-based analysis for identification of urethrovesical subregions predicting urinary toxicity after prostate cancer radiation therapy","volume":"104","author":"Mylona","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2025.100855_b0075","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ijrobp.2016.10.024","article-title":"Modeling urinary dysfunction after external beam radiation therapy of the prostate using bladder dose-surface maps: evidence of spatially variable response of the bladder surface","volume":"97","author":"Yahya","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2025.100855_b0080","unstructured":"Peura M, Peura M, Iivarinen J. Efficiency of simple shape descriptors. In: Aspects of Visual form 1997:443--451."},{"key":"10.1016\/j.phro.2025.100855_b0085","unstructured":"Van Der Maaten L, Hinton G. Visualizing Data using t-SNE. vol. 9. 2008."},{"key":"10.1016\/j.phro.2025.100855_b0090","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1109\/34.1000236","article-title":"Mean shift: a robust approach toward feature space analysis","volume":"24","author":"Comaniciu","year":"2002","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"year":"2002","series-title":"SAS for lineal models","author":"Littell","key":"10.1016\/j.phro.2025.100855_b0095"},{"key":"10.1016\/j.phro.2025.100855_b0100","article-title":"PREVIS: Predictive visual analytics of anatomical variability for radiotherapy decision support","volume":"97","author":"Furmanov\u00e1","year":"2021","journal-title":"Comput Graph (Pergamon)"},{"key":"10.1016\/j.phro.2025.100855_b0105","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1088\/0031-9155\/56\/4\/011","article-title":"A population-based model to describe geometrical uncertainties in radiotherapy: applied to prostate cases","volume":"56","author":"Budiarto","year":"2011","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.phro.2025.100855_b0110","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.ijrobp.2009.02.090","article-title":"Radiation dose-volume effects of the urinary bladder","volume":"76","author":"Viswanathan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2025.100855_b0115","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.ijrobp.2018.08.015","article-title":"A systematic post-QUANTEC review of tolerance doses for late toxicity after prostate cancer radiation therapy","volume":"102","author":"Olsson","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2025.100855_b0120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.phro.2020.08.002","article-title":"Towards spatial representations of dose distributions to predict risk of normal tissue morbidity after radiotherapy","volume":"15","author":"Casares-Magaz","year":"2020","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.phro.2025.100855_b0125","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.radonc.2020.02.028","article-title":"Local dose analysis to predict acute and late urinary toxicities after prostate cancer radiotherapy: assessment of cohort and method effects","volume":"147","author":"Mylona","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2025.100855_b0130","article-title":"Impact of daily plan adaptation on accumulated doses in ultra-hypofractionated magnetic resonance-guided radiation therapy of prostate cancer","volume":"29","author":"Xiong","year":"2024","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.phro.2025.100855_b0135","article-title":"Predicting cervical cancer target motion using a multivariate regression model to enable patient selection for adaptive external beam radiotherapy","volume":"29","author":"Wang","year":"2024","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.phro.2025.100855_b0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.phro.2021.09.004","article-title":"Intrafractional motion models based on principal components in magnetic resonance guided prostate radiotherapy","volume":"20","author":"Fransson","year":"2021","journal-title":"Phys Imaging Radiat Oncol"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631625001605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631625001605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T04:28:46Z","timestamp":1765859326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631625001605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":28,"alternative-id":["S2405631625001605"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2025.100855","relation":{},"ISSN":["2405-6316"],"issn-type":[{"type":"print","value":"2405-6316"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of genitourinary late effects after radiotherapy for prostate cancer associated with early changes in bladder shape","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2025.100855","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100855"}}